参考文献
2020-10-22
1: Cardenas MG, Yu W, Beguelin W, Teater MR, Geng H, Goldstein RL, Oswald E,
Hatzi K, Yang SN, Cohen J, Shaknovich R, Vanommeslaeghe K, Cheng H, Liang D, Cho
HJ, Abbott J, Tam W, Du W, Leonard JP, Elemento O, Cerchietti L, Cierpicki T, Xue
F, MacKerell AD Jr, Melnick AM. Rationally designed BCL6 inhibitors target
activated B cell diffuse large B cell lymphoma. J Clin Invest. 2016 Sep
1;126(9):3351-62. doi: 10.1172/JCI85795. Epub 2016 Aug 2. PubMed PMID: 27482887;
PubMed Central PMCID: PMC5004937.
Hatzi K, Yang SN, Cohen J, Shaknovich R, Vanommeslaeghe K, Cheng H, Liang D, Cho
HJ, Abbott J, Tam W, Du W, Leonard JP, Elemento O, Cerchietti L, Cierpicki T, Xue
F, MacKerell AD Jr, Melnick AM. Rationally designed BCL6 inhibitors target
activated B cell diffuse large B cell lymphoma. J Clin Invest. 2016 Sep
1;126(9):3351-62. doi: 10.1172/JCI85795. Epub 2016 Aug 2. PubMed PMID: 27482887;
PubMed Central PMCID: PMC5004937.
